LTA and neoplasm: In line with such findings, B16.F10 melanoma-bearing mice treated with a tumor-targeted GD2 scFv-LTα fusion protein demonstrate increased densities of intratumoral HEV and develop a diverse T cell repertoire in association with TLS neogenesis (43).